Ironveld – having argued asset “potential value many times in excess of the company's market capitalisation”… massively discounted placing & worse!...
Some good news, I think, for shareholders in AIM-listed medical technology firm Angle (AGL) which one might sense will be greeted with the same relief as the moment when an unwelcome guest leaves the house.
Well, done, Cenkos. As Nomad you appear to have forced a bit more truth out of your client at Quindell. But you are also Nomad (and Broker) to Angle plc (AGL).
Search ShareProphets |
Recent Comments |